Thrive Primary Care, a membership-based family medicine practice, is outlining federal guidance on radiofrequency (RF) microneedling for people considering Morpheus8 treatment under the eyes. The U.S. Food and Drug Administration (FDA) issued the guidance in a safety communication dated October 15, 2025. The practice’s guide to microneedling for acne scars explains how Morpheus8 uses RF microneedling, the technology covered by the FDA communication.
The FDA stated it is aware of serious complications reported with certain uses of RF microneedling devices in skin procedures. Reported complications include burns, scarring, fat loss, disfigurement, and nerve damage. Some cases required surgical repair or medical intervention. The agency said its evaluation was ongoing and that it would keep the public informed of significant new information.
RF microneedling devices, including Morpheus8, deliver radiofrequency energy into and under the skin through an array of small electrodes called microneedles. The FDA communication does not name specific products. The FDA’s 510(k) clearances for Morpheus8 applicators specify the types of procedures they are cleared for but do not specifically mention the eye area.
For patients, the FDA recommends seeking care from a licensed health care provider trained and experienced in using RF microneedling devices. It also advises asking which devices the provider plans to use so patients can look them up in the FDA’s public 510(k) database. Patients are encouraged to discuss the benefits and risks of all available skin procedures.
The agency describes RF microneedling, which is used to improve the appearance of skin, as a medical procedure rather than a cosmetic treatment. It says the devices should not be used at home. Patients who experience problems after a procedure are advised to seek care from a licensed provider and to report the problem to the FDA.
Skin on the lower eyelid is among the thinnest on the body and has little to no subcutaneous fat, so underlying features show through. Thrive states that it customizes needle depth and energy settings based on each patient’s skin concerns. A consultation can clarify whether Morpheus8 is appropriate for the patient’s specific under-eye concern.
Thrive lists fine lines, uneven texture, and mild skin laxity as concerns Morpheus8 commonly addresses. It describes the treatment as combining microneedling with radiofrequency energy to trigger the body’s natural healing response and support collagen production. The practice says improvements may appear gradually over weeks and months, and more than one session may be needed.
Some under-eye changes arise from structure rather than skin quality. According to Mayo Clinic, bags under the eyes form when tissues supporting the eyelids weaken and fat around the eye shifts into the lower eyelid. Shadows cast by puffy eyelids or hollows that develop with age can also resemble dark circles.
Structural changes of that kind are not among the concerns Thrive lists for Morpheus8. Distinguishing skin-quality concerns from changes in eyelid support or fat position is part of choosing an approach. For separate concerns such as surface pigmentation or redness, Thrive says patients can combine Morpheus8 treatment with Alma Laser therapies.
Thrive describes Morpheus8 recovery as involving some downtime. The practice says redness, mild swelling, and sensitivity are expected for the first day or two.
Anyone researching Morpheus8 treatment under the eyes can treat the FDA recommendations as a starting checklist. Thrive Primary Care is a locally owned practice in Folsom, CA, with three board-certified family physicians serving the greater Sacramento region. The practice offers Morpheus8 RF microneedling and states that a physician guides every session.
###
For more information about Thrive Primary Care, contact the company here:
Thrive Primary Care
Thrive Primary Care
+19162388494
info@thriveprimarycare.net
2390 E Bidwell St #300, Folsom, CA 95630, USA
